Hofseth Biocare ASA (HBC) — Cash Flow Quality Index

Latest as of June 2023: 0.55x

Hofseth Biocare ASA (HBC) has a Cash Flow Quality Index of 0.55x as of June 2023. Operating cash flow of Nkr3.16 Million is below net income of Nkr5.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Hofseth Biocare ASA generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

0.55x
Operating CF / Net Income

Operating Cash Flow

Nkr3.16 Million
NOK

Net Income

Nkr5.76 Million
NOK

Data as of

Jun 2023
Most recent filing

Annual Cash Flow Quality Index for Hofseth Biocare ASA (None–None)

Year-by-year earnings quality comparison for Hofseth Biocare ASA. For live market cap and the full company financial profile, see Hofseth Biocare ASA stock valuation.

Year Quality Index Operating CF (NOK) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.